SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 52 filers reported holding SIO GENE THERAPIES INC in Q4 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $756,867 | +46.7% | 1,739,923 | -5.5% | 0.00% | – |
| Q3 2022 | $516,000 | -31.7% | 1,840,707 | -12.3% | 0.00% | – |
| Q2 2022 | $756,000 | -46.2% | 2,098,581 | 0.0% | 0.00% | – |
| Q1 2022 | $1,406,000 | -49.3% | 2,098,581 | -2.4% | 0.00% | – |
| Q4 2021 | $2,773,000 | -37.7% | 2,149,152 | +4.7% | 0.00% | – |
| Q3 2021 | $4,454,000 | -16.3% | 2,052,488 | +5.3% | 0.00% | – |
| Q2 2021 | $5,319,000 | +98.4% | 1,948,262 | +89.7% | 0.00% | – |
| Q1 2021 | $2,681,000 | -12.4% | 1,027,290 | -6.7% | 0.00% | – |
| Q4 2020 | $3,062,000 | – | 1,101,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sassicaia Capital Advisers LLC | 310,500 | $863,000 | 1.79% |
| Consonance Capital Management LP | 3,186,335 | $8,858,000 | 0.83% |
| Opaleye Management Inc. | 2,000,000 | $5,560,000 | 0.73% |
| Sio Capital Management, LLC | 886,665 | $2,465,000 | 0.50% |
| Rubric Capital Management LP | 2,335,200 | $6,492,000 | 0.48% |
| Affinity Asset Advisors, LLC | 250,000 | $695,000 | 0.37% |
| GSA CAPITAL PARTNERS LLP | 354,265 | $985,000 | 0.16% |
| Hudson Bay Capital Management LP | 3,200,000 | $8,896,000 | 0.05% |
| Insight Advisors, LLC/ PA | 24,000 | $67,000 | 0.02% |
| Maven Securities LTD | 86,788 | $246,000 | 0.02% |